Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,363 | 187 | 99.7% |
| Education | $11.02 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $574.74 | 35 | $0 (2024) |
| PFIZER INC. | $446.43 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $386.30 | 18 | $0 (2023) |
| AbbVie Inc. | $307.99 | 20 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $273.39 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $268.47 | 19 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $160.00 | 4 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $151.59 | 4 | $0 (2021) |
| Amgen Inc. | $121.11 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $116.82 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.09 | 5 | PFIZER INC. ($34.15) |
| 2023 | $534.46 | 28 | GlaxoSmithKline, LLC. ($207.94) |
| 2022 | $612.35 | 38 | GlaxoSmithKline, LLC. ($164.18) |
| 2021 | $503.15 | 34 | PFIZER INC. ($149.03) |
| 2020 | $124.35 | 7 | PFIZER INC. ($56.29) |
| 2019 | $158.59 | 7 | Novo Nordisk Inc ($119.31) |
| 2018 | $380.89 | 14 | Novartis Pharmaceuticals Corporation ($135.34) |
| 2017 | $978.40 | 56 | Janssen Pharmaceuticals, Inc ($268.47) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-ANXIETY | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 01/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: Cardiovascular | ||||||
| 11/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Bone Health | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: UROLOGY | ||||||
| 07/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes Care | ||||||
| 05/09/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 421 | 775 | $100,295 | $43,173 |
| 2022 | 18 | 945 | 1,343 | $137,753 | $67,799 |
| 2021 | 25 | 1,219 | 1,968 | $147,857 | $74,379 |
| 2020 | 19 | 971 | 1,566 | $119,797 | $54,019 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 153 | 399 | $39,920 | $15,401 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 131 | 215 | $30,100 | $11,504 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 75 | 75 | $13,125 | $8,604 | 65.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 20 | $6,500 | $2,315 | 35.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 26 | $4,550 | $1,961 | 43.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 12 | 13 | $2,860 | $1,820 | 63.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 27 | $3,240 | $1,568 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 292 | $29,916 | $15,455 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 199 | $31,356 | $14,677 | 46.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 63 | 134 | $21,734 | $9,942 | 45.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 44 | $13,494 | $6,425 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 70 | 98 | $9,800 | $4,770 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 53 | $7,420 | $3,757 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $4,250 | $2,745 | 64.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 50 | $5,818 | $2,615 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 17 | 17 | $2,975 | $1,954 | 65.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 26 | $2,882 | $1,319 | 45.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 19 | 22 | $1,430 | $974.18 | 68.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 57 | 59 | $1,180 | $620.07 | 52.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 43 | 43 | $1,075 | $573.30 | 53.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 39 | 42 | $798.00 | $406.22 | 50.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 46 | 56 | $728.00 | $360.76 | 49.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $674.00 | $324.69 | 48.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 23 | 29 | $464.00 | $243.90 | 52.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 69 | $345.00 | $206.01 | 59.7% |
About Dr. James Beaton, M.D
Dr. James Beaton, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952416653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Beaton, M.D has received a total of $3,374 in payments from pharmaceutical and medical device companies, with $82.09 received in 2024. These payments were reported across 189 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,363).
As a Medicare-enrolled provider, Beaton has provided services to 3,556 Medicare beneficiaries, totaling 5,652 services with total Medicare billing of $239,370. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 08/20/2006
- Last Updated 03/29/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952416653
Products in Payments
- ELIQUIS (Drug) $363.65
- TRELEGY ELLIPTA (Drug) $248.38
- UBRELVY (Drug) $232.04
- FARXIGA (Drug) $225.80
- Ozempic (Drug) $205.40
- XARELTO (Drug) $169.09
- ENTRESTO (Drug) $160.00
- JARDIANCE (Drug) $151.59
- Tresiba (Drug) $131.18
- AREXVY (Drug) $123.74
- INVOKANA (Drug) $99.38
- CHANTIX (Drug) $82.78
- HawkOne (Device) $79.99
- Victoza (Drug) $78.78
- EVENITY (Biological) $75.42
- Rybelsus (Drug) $72.47
- GEMTESA (Drug) $58.75
- TOUJEO (Drug) $55.44
- TRINTELLIX (Drug) $55.21
- VRAYLAR (Drug) $45.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Mark Bradshaw, M.d, M.D
Family Medicine — Payments: $5,627
Dr. Willard Burks, M.d, M.D
Family Medicine — Payments: $5,354
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Sean Koch, Md, MD
Family Medicine — Payments: $3,138
Jeremiah Nugent, M.d, M.D
Family Medicine — Payments: $2,336
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90